Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon.

Kuca K, Jun D, Junova L, Musilek K, Hrabinova M, da Silva JAV, Ramalho TC, Valko M, Wu Q, Nepovimova E, França TCC.

Molecules. 2018 May 7;23(5). pii: E1103. doi: 10.3390/molecules23051103.

2.

Protective role of quercetin against copper(II)-induced oxidative stress: A spectroscopic, theoretical and DNA damage study.

Jomova K, Lawson M, Drostinova L, Lauro P, Poprac P, Brezova V, Michalik M, Lukes V, Valko M.

Food Chem Toxicol. 2017 Dec;110:340-350. doi: 10.1016/j.fct.2017.10.042. Epub 2017 Oct 26.

PMID:
29107026
3.

Targeting Free Radicals in Oxidative Stress-Related Human Diseases.

Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M.

Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24. Review.

PMID:
28551354
4.

MRI assessment of bone structure and microarchitecture.

Chang G, Boone S, Martel D, Rajapakse CS, Hallyburton RS, Valko M, Honig S, Regatte RR.

J Magn Reson Imaging. 2017 Aug;46(2):323-337. doi: 10.1002/jmri.25647. Epub 2017 Feb 6. Review.

5.

Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules.

Hamulakova S, Poprac P, Jomova K, Brezova V, Lauro P, Drostinova L, Jun D, Sepsova V, Hrabinova M, Soukup O, Kristian P, Gazova Z, Bednarikova Z, Kuca K, Valko M.

J Inorg Biochem. 2016 Aug;161:52-62. doi: 10.1016/j.jinorgbio.2016.05.001. Epub 2016 May 5.

PMID:
27230386
6.

Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.

Valko M, Jomova K, Rhodes CJ, Kuča K, Musílek K.

Arch Toxicol. 2016 Jan;90(1):1-37. doi: 10.1007/s00204-015-1579-5. Epub 2015 Sep 7. Review.

PMID:
26343967
7.

Calculations of hyperfine coupling constant of copper(II) in aqueous environment. Finite temperature molecular dynamics and relativistic effects.

Malček M, Bučinský L, Valko M, Biskupič S.

J Mol Model. 2015 Sep;21(9):237. doi: 10.1007/s00894-015-2752-8. Epub 2015 Aug 18.

PMID:
26280985
8.

Synthesis, crystal structure, spectroscopic properties and potential biological activities of salicylate‒neocuproine ternary copper(II) complexes.

Kucková L, Jomová K, Švorcová A, Valko M, Segľa P, Moncoľ J, Kožíšek J.

Molecules. 2015 Jan 27;20(2):2115-37. doi: 10.3390/molecules20022115.

9.

EPR spectroscopy of a clinically active (1:2) copper(II)-histidine complex used in the treatment of Menkes disease: a Fourier transform analysis of a fluid CW-EPR spectrum.

Gala L, Lawson M, Jomova K, Zelenicky L, Congradyova A, Mazur M, Valko M.

Molecules. 2014 Jan 15;19(1):980-91. doi: 10.3390/molecules19010980.

10.

Health protective effects of carotenoids and their interactions with other biological antioxidants.

Jomova K, Valko M.

Eur J Med Chem. 2013;70:102-10. doi: 10.1016/j.ejmech.2013.09.054. Epub 2013 Oct 6. Review.

PMID:
24141200
11.

Outlier detection for patient monitoring and alerting.

Hauskrecht M, Batal I, Valko M, Visweswaran S, Cooper GF, Clermont G.

J Biomed Inform. 2013 Feb;46(1):47-55. doi: 10.1016/j.jbi.2012.08.004. Epub 2012 Aug 27.

12.

Redox cycling mechanisms in the colon.

Jomova K, Valko M.

Med Hypotheses. 2012 Sep;79(3):418-9. doi: 10.1016/j.mehy.2012.05.012. Epub 2012 Jun 7. No abstract available.

PMID:
22683236
13.

Identification of microbial and proteomic biomarkers in early childhood caries.

Hart TC, Corby PM, Hauskrecht M, Hee Ryu O, Pelikan R, Valko M, Oliveira MB, Hoehn GT, Bretz WA.

Int J Dent. 2011;2011:196721. doi: 10.1155/2011/196721. Epub 2011 Oct 16.

14.

Importance of iron chelation in free radical-induced oxidative stress and human disease.

Jomova K, Valko M.

Curr Pharm Des. 2011;17(31):3460-73. Review.

PMID:
21902663
15.

A tetranuclear copper(II) cluster: bis(μ-4-chlorobenzoato-κ2O:O')(4-chlorobenzoato-κ2O,O')(4-chlorobenzoato-κO)tetrakis(μ3-2-pyridylmethanolato-κ4N,O:O:O)tetracopper(II).

Moncol J, Jomova K, Zelenicky L, Lis T, Valko M.

Acta Crystallogr C. 2011 Sep;67(Pt 9):m318-20. doi: 10.1107/S010827011103335X. Epub 2011 Aug 31.

PMID:
21881181
16.

Advances in metal-induced oxidative stress and human disease.

Jomova K, Valko M.

Toxicology. 2011 May 10;283(2-3):65-87. doi: 10.1016/j.tox.2011.03.001. Epub 2011 Mar 23. Review.

PMID:
21414382
17.

Conditional outlier detection for clinical alerting.

Hauskrecht M, Valko M, Batal I, Clermont G, Visweswaran S, Cooper GF.

AMIA Annu Symp Proc. 2010 Nov 13;2010:286-90.

18.

Arsenic: toxicity, oxidative stress and human disease.

Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M.

J Appl Toxicol. 2011 Mar;31(2):95-107. doi: 10.1002/jat.1649. Epub 2011 Feb 14. Review.

PMID:
21321970
19.

Conditional Anomaly Detection with Soft Harmonic Functions.

Valko M, Kveton B, Valizadegan H, Cooper GF, Hauskrecht M.

Proc IEEE Int Conf Data Min. 2011;2011:735-743.

20.

Feature importance analysis for patient management decisions.

Valko M, Hauskrecht M.

Stud Health Technol Inform. 2010;160(Pt 2):861-5.

Supplemental Content

Loading ...
Support Center